1. Home
  2. ALT vs PGC Comparison

ALT vs PGC Comparison

Compare ALT & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • PGC
  • Stock Information
  • Founded
  • ALT 1997
  • PGC 1921
  • Country
  • ALT United States
  • PGC United States
  • Employees
  • ALT 59
  • PGC N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • PGC Commercial Banks
  • Sector
  • ALT Health Care
  • PGC Finance
  • Exchange
  • ALT Nasdaq
  • PGC Nasdaq
  • Market Cap
  • ALT 501.9M
  • PGC 450.8M
  • IPO Year
  • ALT N/A
  • PGC N/A
  • Fundamental
  • Price
  • ALT $4.86
  • PGC $25.97
  • Analyst Decision
  • ALT Strong Buy
  • PGC Strong Buy
  • Analyst Count
  • ALT 7
  • PGC 2
  • Target Price
  • ALT $16.33
  • PGC $37.00
  • AVG Volume (30 Days)
  • ALT 3.2M
  • PGC 150.0K
  • Earning Date
  • ALT 11-06-2025
  • PGC 11-07-2025
  • Dividend Yield
  • ALT N/A
  • PGC 0.80%
  • EPS Growth
  • ALT N/A
  • PGC 6.12
  • EPS
  • ALT N/A
  • PGC 1.93
  • Revenue
  • ALT $20,000.00
  • PGC $248,809,000.00
  • Revenue This Year
  • ALT N/A
  • PGC $27.34
  • Revenue Next Year
  • ALT N/A
  • PGC $16.59
  • P/E Ratio
  • ALT N/A
  • PGC $12.99
  • Revenue Growth
  • ALT N/A
  • PGC 18.63
  • 52 Week Low
  • ALT $2.90
  • PGC $23.96
  • 52 Week High
  • ALT $10.88
  • PGC $37.68
  • Technical
  • Relative Strength Index (RSI)
  • ALT 68.61
  • PGC 48.38
  • Support Level
  • ALT $4.40
  • PGC $24.97
  • Resistance Level
  • ALT $4.75
  • PGC $26.79
  • Average True Range (ATR)
  • ALT 0.29
  • PGC 0.89
  • MACD
  • ALT 0.07
  • PGC 0.06
  • Stochastic Oscillator
  • ALT 95.22
  • PGC 54.33

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

Share on Social Networks: